ProShare Advisors
ORTX

ProShare Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

ProShare Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,575
Closed -$36K – 2354
2021
Q3 		$36K Buy
1,575
+374
+31% +$11.1K ﹤0.01% 1984
2021
Q2 		$53K Buy
+1,201
New +$66.9K ﹤0.01% 2355

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

ProShare Advisors's ORTX Position: Q4 2021 in Review

ProShare Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 1,575 shares — an estimated $36K sold.

ProShare Advisors first reported a position in ORTX in Q2 2021 and held it in 2 quarters. The position peaked at $53K in Q2 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • ProShare Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • ProShare Advisors sold 1,575 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $36K.
  • ProShare Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 2 quarters.
  • ProShare Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $53K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.